Perspective Therapeutics pre-announces ~$9.4M cash; launches stock offering

Perspective Therapeutics, Inc.

Preliminary cash and cash equivalents of ~$9.4M as of Dec 31, 2023 (unaudited).
Sold 1.24M shares at avg $0.303 under ATM program, generating ~$376k gross proceeds.
Filed preliminary prospectus for proposed common stock offering (size not disclosed).
Preliminary data subject to change upon completion of audit and year-end procedures.

item 2.02

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Perspective Therapeutics, Inc. reported preliminary financial results for the year ended December 31, 2023.

Period: the year ended December 31, 2023
Result: preliminary results

Exact text from the filing

The Preliminary Prospectus Supplement contains certain information and preliminary estimates regarding the Company's financial results for the year ended December 31, 2023, which are set forth below.

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-001533

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.